Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTD1801 Phase 2 Study in Type 2 Diabetes Mellitus
ChiCTR2400087956Phase 2Completed
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of berberine ursodeoxycholate in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Peking University People's Hospital. Primary endpoint: Change in HbA1c. Started Aug 2024; status: completed.
02
Drugs
berberine ursodeoxycholate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2400087956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087956.